EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
107 hedge funds and large institutions have $163M invested in Eagle Pharmaceuticals, Inc. in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 48 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
61% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 31
Holders
107
Holding in Top 10
1
Calls
$22K
Puts
$21K
Top Buyers
| 1 | +$4.62M | |
| 2 | +$1.58M | |
| 3 | +$1.37M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$1.21M |
| 5 |
Millennium Management
New York
|
+$1.04M |
Top Sellers
| 1 | -$1.92M | |
| 2 | -$1.89M | |
| 3 | -$1.6M | |
| 4 |
E
Ergoteles
New York
|
-$1.35M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.34M |